{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:54:23Z","timestamp":1787500463734,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.thromres.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:52:06Z","timestamp":1710460326000},"page":"34-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban"],"prefix":"10.1016","volume":"237","author":[{"given":"Cindy","family":"Pereira Portela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stirnimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Kr\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Veuthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime G.","family":"Zermatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Bertaggia Calderara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.thromres.2024.03.006_bb0005","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.amjmed.2017.05.011","article-title":"Influences of obesity and bariatric surgery on the clinical and pharmacologic profile of rivaroxaban","volume":"130","author":"Moore","year":"2017","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2024.03.006_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102408","article-title":"Can we use NOACS in APS?","volume":"18","author":"Peleg","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.thromres.2024.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bcp.13243","article-title":"Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery","volume":"83","author":"Kroll","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.thromres.2024.03.006_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1113-0655","article-title":"Does one dose really fit all? On the monitoring of direct oral anticoagulants: a review of the literature","volume":"40","author":"Moner-Banet","year":"2020","journal-title":"Hamostaseologie"},{"issue":"13","key":"10.1016\/j.thromres.2024.03.006_bb0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.thromres.2024.03.006_bb0030","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.2020005319","article-title":"Anticoagulant activity of edoxaban in patients with cirrhosis","volume":"136","author":"Bos","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.03.006_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1033416","article-title":"Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases","volume":"9","author":"Valke","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2024.03.006_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2020.01.012","article-title":"Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters","volume":"187","author":"Bertaggia Calderara","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.03.006_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.717939","article-title":"Automated thrombin generation assay for rivaroxaban, Apixaban, and edoxaban measurements","volume":"8","author":"Meihandoest","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.03.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.12767","article-title":"Effect of rivaroxaban on thrombin generation in vivo. A study in obese patients","volume":"40","author":"Bertaggia-Calderara","year":"2018","journal-title":"Int. J. Lab. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:13Z","timestamp":1758736333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"alternative-id":["S0049384824000781"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.03.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}